Sponsor

Clinical trials sponsored by Brigham and Women's Hospital

Active studies whose public registry record names Brigham and Women's Hospital as lead sponsor.

21active studies

7recruiting now

2countries represented

36largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 2

Study of Tirzepatide for Recovery and Alcohol Use Management

Alcohol Use Disorder (AUD)Condition

Tirzepatide, Saline PlaceboTreatment

United States2 locations

Brigham and Women's HospitalSponsor

Updated 2026-07-09 · NCT06727331See eligibility →

Recruiting nowNot applicable

Addressing the Double Burden of Malnutrition in Guatemala

Maternal Obesity Complicating Pregnancy, Birth,or Puerperium, Child MalnutritionCondition

Family food ration, Optimal weight counselingTreatment

Guatemala1 locations

Brigham and Women's HospitalSponsor

Updated 2026-05-22 · NCT06750120See eligibility →

Recruiting nowPhase 4

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Type2Diabetes, ASCVDCondition

SGLT2 inhibitor, GLP-1 receptor agonistTreatment

United States36 locations

Brigham and Women's HospitalSponsor

Updated 2026-04-13 · NCT05390892See eligibility →

Recruiting nowNot applicable

Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease, Non-alcoholic SteatohepatitisCondition

Endoscopic ultrasound shear wave elastographyTreatment

United States2 locations

Brigham and Women's HospitalSponsor

Updated 2026-03-02 · NCT05728697See eligibility →

Recruiting nowNot applicable

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Overweight and ObesityCondition

24-hour ambulatory blood pressure, Liberal salt dietTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2025-12-10 · NCT06069622See eligibility →

Recruiting nowNot applicable

Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

Appetitive Behavior, ObesityCondition

Repetitive Transcranial Magnetic Stimulation (rTMS), Sham repetitive Transcranial Magnetic Stimulation (rTMS)Treatment

United States2 locations

Brigham and Women's HospitalSponsor

Updated 2025-12-05 · NCT06105164See eligibility →

Recruiting nowPhase 2

Semaglutide for Helping Opioid Recovery

Opioid Use DisorderCondition

Semaglutide, PlaceboTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2025-09-26 · NCT06639464See eligibility →

Opening soonPhase 2

Tirzepatide for the Treatment of Cannabis Use Disorder

Cannabis Use DisorderCondition

Tirzepatide, PlaceboTreatment

Locations pending0 locations

Brigham and Women's HospitalSponsor

Updated 2025-12-18 · NCT07265752See eligibility →

Opening soonNot applicable

Endoscopic Sleeve Gastroplasty Technique Comparison for Weight Loss

Obesity, Obesity, MorbidCondition

Endoscopic Sleeve Gastroplasty - Belt and Suspenders, Endoscopic Sleeve Gastroplasty - BeltTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2025-12-02 · NCT06299644See eligibility →

Invitation onlyNot applicable

Water is K'é: Multi-level Intervention to Promote Healthy Beverage Choices Among Navajo Families

Water, Child NutritionCondition

Water is K'éTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2025-03-24 · NCT06020027See eligibility →

Active, not recruitingNot applicable

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

Cardiovascular Events, Type2 DiabetesCondition

SGLT2 inhibitor, DPP-4 inhibitorTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2026-08-13 · NCT05220917See eligibility →

Active, not recruitingNot applicable

Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)

Type 2 Diabetes, Heart FailureCondition

Oral semaglutide, SitagliptinTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2026-07-01 · NCT07390110See eligibility →

Active, not recruitingNot applicable

Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity

Obesity, Weight LossCondition

Bariatric Endoscopic Antral MyotomyTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2026-06-25 · NCT05713071See eligibility →

Active, not recruitingNot applicable

Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

Type 2 Diabetes, Heart FailureCondition

Tirzepatide, SemaglutideTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2026-05-15 · NCT06980623See eligibility →

Active, not recruitingNot applicable

Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C

Bariatric Surgery, Sleeve GastrectomyCondition

Dietary habits planTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2025-12-05 · NCT03482986See eligibility →

Active, not recruitingNot applicable

Role of Dietary Habits in Efficacy of Bariatric Surgery - Study B

Bariatric Surgery, Sleeve GastrectomyCondition

In-laboratory assessmentTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2025-12-04 · NCT03467906See eligibility →

Active, not recruitingNot applicable

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Non-alcoholic Steatohepatitis (NASH), Endoscopic Sleeve GastroplastyCondition

Insulin Resistance, Quality of Life AssessmentTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2025-12-02 · NCT04820036See eligibility →

Active, not recruitingNot applicable

Partnerships for Reducing Overweight and Obesity with Patient-Centered Strategies 2.0

Overweight, ObesityCondition

Online Weight Management Program with Coaching and Patient Navigator SupportTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2025-02-06 · NCT05553925See eligibility →

Active, not recruitingNot applicable

Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes

PreDiabetes, Insulin ResistanceCondition

Palmitoleic acid, PlaceboTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2025-02-05 · NCT05560971See eligibility →

Active, not recruitingNot applicable

BMI-based Vitamins in Obese Pregnant Women

ObesityCondition

BMI-based prenatal vitamin, Standard prenatal vitaminTreatment

United States2 locations

Brigham and Women's HospitalSponsor

Updated 2024-12-10 · NCT02802566See eligibility →

Active, not recruitingNot applicable

Obesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic Neuralgia

Herpes Zoster (HZ)Condition

Intervention not listedTreatment

Locations pending0 locations

Brigham and Women's HospitalSponsor

Updated 2024-10-15 · NCT06638177See eligibility →

Related sponsors

Novo Nordisk A/S71 Eli Lilly and Company67 University of Colorado, Denver36 Cairo University31 Mayo Clinic29 Norwegian University of Science and Technology25

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.